Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Repeated infusions of VWF/FVIII concentrate: impact of VWF:FVIII ratio on FVIII trough and peak levels in a rabbit model.

Raquet E, Stockschläder M, Dickneite G.

Haemophilia. 2011 Sep;17(5):808-14. doi: 10.1111/j.1365-2516.2011.02603.x. Epub 2011 Jul 4.

PMID:
21726357
2.

Fetal alloimmune thrombocytopenia and maternal intravenous immunoglobulin infusion.

Giers G, Wenzel F, Stockschläder M, Riethmacher R, Lorenz H, Tutschek B.

Haematologica. 2010 Nov;95(11):1921-6. doi: 10.3324/haematol.2010.025106. Epub 2010 Jun 9.

3.

Retrospective comparison of maternal vs. HPA-matched donor platelets for treatment of fetal alloimmune thrombocytopenia.

Giers G, Wenzel F, Fischer J, Stockschläder M, Riethmacher R, Lorenz H, Tutschek B.

Vox Sang. 2010 Apr;98(3 Pt 2):423-30. doi: 10.1111/j.1423-0410.2009.01268.x. Epub 2009 Oct 27.

PMID:
19874573
4.

Induction of tolerance after combined immunosuppression and -adsorption in two patients with acquired haemophilia after severe haemorrhages controlled by sequential administration of rFVIIa and FEIBA.

Stockschläder M, Ruf L, Linderer A, Schroeder T, Knoefel WT, Haas R, Giers G, Gerhardt A, Sucker C, Zotz RB, Scharf RE.

Thromb Haemost. 2009 Mar;101(3):586-90. No abstract available.

PMID:
19277426
5.

Fatal bleeding due to a heparin-like anticoagulant in a 37-year-old woman suffering from systemic mastocytosis.

Sucker C, Mansmann G, Steiner S, Gattermann N, Schmitt-Graeff A, Loncar R, Scharf RE, Stockschlader M.

Clin Appl Thromb Hemost. 2008 Jul;14(3):360-4. Epub 2007 Dec 26.

PMID:
18160568
6.

Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience.

Fürst G, Schulte am Esch J, Poll LW, Hosch SB, Fritz LB, Klein M, Godehardt E, Krieg A, Wecker B, Stoldt V, Stockschläder M, Eisenberger CF, Mödder U, Knoefel WT.

Radiology. 2007 Apr;243(1):171-9. Epub 2007 Feb 20.

PMID:
17312278
7.

[Therapy-resistant cutaneous infiltrates in chronic lymphocytic leukemia].

Sucker C, Lorenz G, Dölken G, Stockschläder M.

Hautarzt. 2006 Nov;57(11):1009-12. German.

PMID:
16425068
8.

Autologous bone marrow-derived stem cell therapy in combination with TMLR. A novel therapeutic option for endstage coronary heart disease: report on 2 cases.

Klein HM, Ghodsizad A, Borowski A, Saleh A, Draganov J, Poll L, Stoldt V, Feifel N, Piecharczek C, Burchardt ER, Stockschläder M, Gams E.

Heart Surg Forum. 2004;7(5):E416-9.

PMID:
15799915
9.

Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration.

am Esch JS 2nd, Knoefel WT, Klein M, Ghodsizad A, Fuerst G, Poll LW, Piechaczek C, Burchardt ER, Feifel N, Stoldt V, Stockschläder M, Stoecklein N, Tustas RY, Eisenberger CF, Peiper M, Häussinger D, Hosch SB.

Stem Cells. 2005 Apr;23(4):463-70.

10.

[Anticoagulation as an oncological therapy principle].

Stockschläder M, Wenzel F, Zotz RB, Scharf RE.

Dtsch Med Wochenschr. 2005 Feb 4;130(5):220-5. Review. German.

PMID:
15678391
11.

Intraoperative isolation and processing of BM-derived stem cells.

Ghodsizad A, Klein HM, Borowski A, Stoldt V, Feifel N, Voelkel T, Piechaczek Ch, Burchardt E, Stockschläder M, Gams E.

Cytotherapy. 2004;6(5):523-6.

PMID:
15512919
12.

[Fracture of the anterior superior iliac spine in a 37-year-old sportsman].

Sucker C, Dölken G, Stockschläder M.

Med Klin (Munich). 2004 Sep 15;99(9):541-2. German. No abstract available.

PMID:
15372185
13.

[Acquired von Willebrand syndrome].

Sucker C, Stockschläder M, Zotz RB, Scharf RE.

Dtsch Med Wochenschr. 2004 Jul 9;129(28-29):1581-5. Review. German. No abstract available.

PMID:
15243910
14.

[Malignant melanoma of the anorectal mucosa].

Sucker C, Dölken G, Stockschläder M.

Dtsch Med Wochenschr. 2004 Jul 2;129(27):1504-6. German.

PMID:
15227591
15.

[Thoracic neuroblastoma in a young adult].

Sucker C, Dölken G, Lorenz G, Fiedler W, Stockschläder M.

Dtsch Med Wochenschr. 2004 Feb 6;129(6):249-52. German.

PMID:
14750051
16.

Filgrastim mobilization and collection of allogeneic blood progenitor cells from adult family donors: first interim report of a prospective German multicenter study.

Beelen DW, Ottinger H, Kolbe K, Pönisch W, Sayer HG, Knauf W, Stockschläder M, Scheid C, Schaefer UW.

Ann Hematol. 2002 Dec;81(12):701-9. Epub 2002 Nov 23.

PMID:
12483366
17.

[Neurotoxicity of 5-fluorouracil].

Sucker C, Lambers C, Stockschläder M, Dölken G.

Dtsch Med Wochenschr. 2002 Sep 27;127(39):2011-4. Review. German. No abstract available.

PMID:
12324882
18.

[Plasma cell infiltration of the liver in multiple myeloma].

Sucker C, Dölken G, Preuss J, Schwesinger G, Stockschläder M.

Dtsch Med Wochenschr. 2002 Jul 5;127(27):1469-72. German. No abstract available.

PMID:
12098098
19.

[Extramedullary plasmacytoma].

Sucker C, Stockschläder M.

Dtsch Med Wochenschr. 2002 Jan 25;127(4):153-5. German. No abstract available.

PMID:
11807659
20.

Expression of the adhesion molecules CD49d and CD49e on G-CSF-mobilized CD34+ cells of patients with solid tumors or non-Hodgkin's and Hodgkin's lymphoma and of healthy donors is inversely correlated with the amount of mobilized CD34+ cells.

Zeller W, Kröger N, Berger J, Krueger W, Dierlamm J, Stockschläder M, Gutensohn K, Hossfeld DK, Zander AR.

J Hematother Stem Cell Res. 1999 Oct;8(5):539-46.

PMID:
10791904
21.

Blood-derived macrophage layers in the presence of hydrocortisone support myeloid progenitors in long-term cultures of CD34+ cord blood and bone marrow cells.

Clausen J, Stockschläder M, Fehse N, Hassan HT, Gabl C, Zander AR.

Ann Hematol. 2000 Feb;79(2):59-65.

PMID:
10741916
22.

Expansion and fibronectin-enhanced retroviral transduction of primary human T lymphocytes for adoptive immunotherapy.

Stockschläder M, Haiss M, Exner S, Schmah O, Veelken H, Follo M, Rüger R, Finke J.

J Hematother Stem Cell Res. 1999 Aug;8(4):401-10.

PMID:
10634178
23.

Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow.

Zander AR, Zabelina T, Kröger N, Renges H, Krüger W, Löliger C, Dürken M, Stockschläder M, de Wit M, Wacker-Backhaus G, Bielack S, Jaburg N, Rüssmann B, Erttmann R, Kabisch H.

Bone Marrow Transplant. 1999 May;23(9):889-93.

24.

High-efficiency retroviral vector-mediated gene transfer into human T lymphocytes.

Li ZX, Schade UM, Fehse B, Stockschläder M, Uhde A, Koch S, Goller B, Rüger R, Fehse N, Zander AR.

Adv Exp Med Biol. 1998;451:375-8. No abstract available.

PMID:
10026899
25.

Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.

Kröger N, Krüger W, Wacker-Backhaus G, Hegewisch-Becker S, Stockschläder M, Fuchs N, Rüssmann B, Renges H, Dürken M, Bielack S, de Wit M, Schuch G, Bartels H, Braumann D, Kuse R, Kabisch H, Erttmann R, Zander AR.

Bone Marrow Transplant. 1998 Dec;22(11):1029-33.

26.

Faster engraftment of peripheral blood progenitor cells compared to bone marrow from unrelated donors.

Ringdén O, Hägglund H, Runde V, Basu O, Kroschinsky F, Stockschläder M, Potter MN.

Bone Marrow Transplant. 1998 Jun;21 Suppl 3:S81-4.

PMID:
9712503
27.

Highly-efficient gene transfer with retroviral vectors into human T lymphocytes on fibronectin.

Fehse B, Schade UM, Li Z, Uhde A, Koch S, Goller B, Rüger R, Fehse N, Stockschläder M, Zander AR.

Br J Haematol. 1998 Jul;102(2):566-74.

PMID:
9695974
28.

Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapy.

Kröger N, Hoffknecht M, Hänel M, Krüger W, Zeller W, Stockschläder M, de Wit M, Weh HJ, Kabisch H, Erttmann R, Zander AR.

Bone Marrow Transplant. 1998 Jun;21(12):1171-5.

29.

Long-term disease-free survival of patients with advanced mantle-cell lymphoma following high-dose chemotherapy.

Kröger N, Hoffknecht M, Dreger P, Krüger W, Zeller W, Krüll A, Stockschläder M, Bittner S, Weh HJ, Zander AR.

Bone Marrow Transplant. 1998 Jan;21(1):55-7.

30.

Selective immunoaffinity-based enrichment of CD34+ cells transduced with retroviral vectors containing an intracytoplasmatically truncated version of the human low-affinity nerve growth factor receptor (deltaLNGFR) gene.

Fehse B, Uhde A, Fehse N, Eckert HG, Clausen J, Rüger R, Koch S, Ostertag W, Zander AR, Stockschläder M.

Hum Gene Ther. 1997 Oct 10;8(15):1815-24.

PMID:
9358031
31.

Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia.

Fielder W, Graeven U, Ergün S, Verago S, Kilic N, Stockschläder M, Hossfeld DK.

Leukemia. 1997 Aug;11(8):1234-7.

PMID:
9264375
32.
33.

Amphotropic murine leukemia viruses induce spongiform encephalomyelopathy.

Münk C, Löhler J, Prassolov V, Just U, Stockschläder M, Stocking C.

Proc Natl Acad Sci U S A. 1997 May 27;94(11):5837-42.

34.

Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia.

Fiedler W, Graeven U, Ergün S, Verago S, Kilic N, Stockschläder M, Hossfeld DK.

Blood. 1997 Mar 15;89(6):1870-5.

35.

Allogeneic transplantation with CD34+-selected cells.

Stockschläder M, Hassan HT, Zeller W, Krüger W, Clausen J, Löliger C, Dieck AT, Kröger N, Link H, Kabisch H, Hossfeld DK, Zander A.

Leuk Lymphoma. 1997 Mar;25(1-2):145-51.

PMID:
9130622
36.

Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantation.

Krüger W, Stockschläder M, Sobottka I, Betker R, De Wit M, Kröger N, Grimm J, Arland M, Fiedler W, Erttmann R, Zander AR.

Leuk Lymphoma. 1997 Feb;24(5-6):491-9.

PMID:
9086439
37.

Long-term follow-up of leukaemia patients after related cryopreserved allogeneic bone marrow transplantation.

Stockschläder M, Hassan HT, Krog C, Krüger W, Löliger C, Horstman M, Altnöder M, Clausen J, Grimm J, Kabisch H, Zander A.

Br J Haematol. 1997 Feb;96(2):382-6.

PMID:
9029030
38.

Nontransferrin-bound iron in serum of patients receiving bone marrow transplants.

Dürken M, Nielsen P, Knobel S, Finckh B, Herrnring C, Dresow B, Kohlschütter B, Stockschläder M, Krüger WH, Kohlschütter A, Zander AR.

Free Radic Biol Med. 1997;22(7):1159-63.

PMID:
9098089
39.

Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.

Hassan HT, Krog C, Stockschläder M, Schleimer B, Zeller W, Krüger W, Erttmann R, Zander AR.

Anticancer Res. 1997 Jan-Feb;17(1B):589-99.

PMID:
9066585
41.
42.
43.

High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors.

Eckert HG, Stockschläder M, Just U, Hegewisch-Becker S, Grez M, Uhde A, Zander A, Ostertag W, Baum C.

Blood. 1996 Nov 1;88(9):3407-15.

44.

Detection of cancer cells in peripheral blood stem cells of women with breast cancer by RT-PCR and cell culture.

Krüger WH, Stockschläder M, Hennings S, Aschenbrenner M, Gruber M, Gutensohn K, Löliger C, Gieseking F, Jonat W, Zander AR.

Bone Marrow Transplant. 1996 Sep;18 Suppl 1:S18-20.

PMID:
8899163
45.

Improved retroviral vectors for hematopoietic stem cell protection and in vivo selection.

Baum C, Eckert HG, Stockschläder M, Just U, Hegewisch-Becker S, Hildinger M, Uhde A, John J, Ostertag W.

J Hematother. 1996 Aug;5(4):323-9. Review.

PMID:
8877707
46.

Serum interleukin-6 levels during bone marrow transplantation: impact on transplant-related toxicity and engraftment.

Steffen M, Dürken M, Pichlmeier U, von dem Busche C, Stockschläder M, Krüger W, Budde-Steffen C, Zander A.

Bone Marrow Transplant. 1996 Aug;18(2):301-7.

PMID:
8864438
47.

Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.

Hassan HT, Zeller W, Stockschläder M, Krüger W, Hoffknecht MM, Zander AR.

Stem Cells. 1996 Jul;14(4):419-29.

48.

Increase of mobilized CD34-positive peripheral blood progenitor cells in patients with Hodgkin's disease, non-Hodgkin's lymphoma, and cancer of the testis.

Zeller W, Gutensohn K, Stockschläder M, Dierlamm J, Kröger N, Koehne G, Hummel K, Kabisch H, Weh HJ, Kühnl P, Hossfeld DK, Zander AR.

Bone Marrow Transplant. 1996 May;17(5):709-13.

PMID:
8733686
49.

G-CSF administration following peripheral blood selected CD34-positive cells autologous transplantation accelerates haematological recovery after myeloablative therapy.

Hassan HT, Stockschläder M, Krüger W, Hoffknecht H, Zander AR.

Br J Haematol. 1996 Mar;92(4):1027-9. No abstract available.

PMID:
8616065
50.

Use of cryopreserved bone marrow in unrelated allogeneic transplantation.

Stockschläder M, Krüger W, tom Dieck A, Horstmann M, Altnöder M, Löliger C, Fiedler W, Hoffknecht M, Erttmann R, Zander A.

Bone Marrow Transplant. 1996 Feb;17(2):197-9. Review.

PMID:
8640166

Supplemental Content

Loading ...
Support Center